Pharmacy and Pharmaceutical Sciences Building
12850 East Montview Boulevard
Aurora, CO 80045
In a Society of Healthcare Epidemiology of American (SHEA) podcast, Dr. Megan Jeffres, PharmD, BCIDP, discusses why intravenous (IV) to oral (PO) conversion has immense potential to benefit patients by preventing unnecessary intravenous therapy associated with risks such as prolonged length of stay, line-associated infections, and excess cost and inconvenience.
Danielle Fixen, PharmD, notes that the role of a pharmacist varies depending on the state, but that pharmacists can perform drug-interaction checks and educate patients on potential side effects they may experience. “Some states have pharmacists within the medical marijuana dispensary while others do not,” she said. “Given the multiple drug interactions with cannabis, it is important to evaluate [its] safety...in patients.”
A new study shows that maybe cannabis doesn't increase heart attack risks, but this study is inconsistent with previous research. Dr. Robert Page, PharmD, noted that “the way cannabis is consumed may make a difference in how it affects the heart and blood vessels. Many people don’t realize that cannabis smoke contains components similar to tobacco smoke.”
Dr. Daniel LaBarbera’s laboratory is engaged in multidisciplinary cancer drug discovery and development - and has been featured in a 2023 peer reviewed cancer research highlight by the DOD's Congressionally Directed Medical Research Programs (CDMRP).
As electronic dance music fans listen to their favorite music this weekend, organizers of the Keep the Party Safe campaign, an effort of CU Pharmacy and the Colorado Consortium for Prescription Drug Abuse Prevention, hope they tune into this message: “We want people to be safe, we want people equipped, we want people to be empowered."